Free Trial

Dark Forest Capital Management LP Purchases New Holdings in Concentrix Co. (NASDAQ:CNXC)

Concentrix logo with Business Services background

Dark Forest Capital Management LP acquired a new position in Concentrix Co. (NASDAQ:CNXC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 29,527 shares of the company's stock, valued at approximately $1,278,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hsbc Holdings PLC grew its holdings in shares of Concentrix by 51.1% during the fourth quarter. Hsbc Holdings PLC now owns 49,633 shares of the company's stock valued at $2,148,000 after buying an additional 16,786 shares in the last quarter. Stifel Financial Corp grew its stake in Concentrix by 119.7% in the fourth quarter. Stifel Financial Corp now owns 79,394 shares of the company's stock valued at $3,435,000 after purchasing an additional 43,263 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Concentrix by 21.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,241 shares of the company's stock worth $140,000 after purchasing an additional 580 shares in the last quarter. MetLife Investment Management LLC grew its stake in shares of Concentrix by 8.2% in the 4th quarter. MetLife Investment Management LLC now owns 26,313 shares of the company's stock valued at $1,139,000 after buying an additional 2,004 shares in the last quarter. Finally, Natixis bought a new position in Concentrix during the fourth quarter valued at approximately $601,000. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Bank of America raised their price target on shares of Concentrix from $58.00 to $59.00 and gave the company a "neutral" rating in a report on Thursday, March 27th. Canaccord Genuity Group lowered their price target on Concentrix from $100.00 to $80.00 and set a "buy" rating on the stock in a report on Thursday, January 16th. Finally, Barrington Research reduced their price objective on shares of Concentrix from $70.00 to $54.00 and set an "outperform" rating for the company in a research note on Monday, March 24th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $69.60.

Check Out Our Latest Report on Concentrix

Concentrix Stock Performance

CNXC stock traded up $0.46 on Monday, reaching $50.67. 139,098 shares of the company were exchanged, compared to its average volume of 699,162. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.42 and a quick ratio of 1.42. Concentrix Co. has a 12 month low of $36.28 and a 12 month high of $77.00. The stock's fifty day moving average price is $47.60 and its 200 day moving average price is $46.27. The firm has a market capitalization of $3.24 billion, a PE ratio of 13.62, a PEG ratio of 0.63 and a beta of 0.51.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported $2.79 EPS for the quarter, topping analysts' consensus estimates of $2.58 by $0.21. The company had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.37 billion. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The company's quarterly revenue was down 1.3% on a year-over-year basis. During the same quarter last year, the company earned $2.57 EPS. On average, research analysts anticipate that Concentrix Co. will post 10.11 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 6th. Investors of record on Friday, April 25th will be paid a $0.3328 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $1.33 dividend on an annualized basis and a yield of 2.63%. Concentrix's payout ratio is currently 33.33%.

Insider Buying and Selling

In related news, CEO Christopher A. Caldwell bought 1,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The stock was acquired at an average price of $46.00 per share, for a total transaction of $46,000.00. Following the transaction, the chief executive officer now directly owns 303,362 shares of the company's stock, valued at $13,954,652. This represents a 0.33 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Cormac J. Twomey sold 500 shares of the company's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $55.60, for a total value of $27,800.00. Following the completion of the sale, the executive vice president now owns 41,111 shares in the company, valued at $2,285,771.60. This trade represents a 1.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,444 shares of company stock valued at $1,484,078 over the last quarter. Corporate insiders own 3.20% of the company's stock.

About Concentrix

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Further Reading

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines